Samantha Zullow

Gastroenterologist and Inflammatory Bowel Disease specialist @BIDMC_GI, GI @NYUlangone @BellevueHosp, IM @BMCimRES, opinions my own

[Crohn's and Colitis Young Adults Network @CCYANetwork]

Research often lumps young adults into the 18–65 age group, ignoring crucial developmental and physiological differences. This leads to misguided treatment decisions and missed chances to improve long-term outcomes for conditions like #IBD.

Read more: https://t.co/pD8ZsCb4x9

[BIDMC_GI @BIDMC_GI]

Colorectal cancer is the #1 cause of cancer death in men under 50. This is why #45istheNew50.

Our team at #BIDMC_GI is here to help schedule your screening.

📞 617-754-8888
💻 https://t.co/xxbsUDgFjD

#ColorectalCancerAwarenessMonth

[BIDMC_GI @BIDMC_GI]

Stay proactive about your health! If you have IBD, you're at a higher risk of colorectal cancer. Talk to our team today about getting your screening.

📞 617-754-8888
💻 https://t.co/xxbsUDgFjD

#ColorectalCancerAwarenessMonth

[Suha Abushamma, MD @SuhaAbushamma]

Common scenario in IBD clinic answered by @sidbarritt4

💎 Isolated HBcAb pts on anti-TNF agents are considered low risk and do not necessarily require HBV prophylaxis

@DCharabaty @IBDConference #AIBD2024

[Omar Tageldin (Tag), MD @OmarMTag]

One of the best summary slides at #AIBD2024 by Dr. Marla Dubinsky:

Specific scenarios for positioning IBD therapy 💉💊

And as Dr. @MLongMD said: “JAKs for joints, ILs for skin”

@IBDConference @DrCoreySiegel @MRegueiroMD @CCYANetwork

Thank you for a wonderful conference 🔥🔥

[Samantha Zullow @SamZullowMD]

#AIBD2024 Algorithm for management for asymptomatic ileitis (incidentally diagnosed terminal ileitis "IDTI" on screening colonoscopy) @IBDConference @tinahamd

[Samantha Zullow @SamZullowMD]

Excellent UP treatment algorithm; consider use of topical/rectal tacrolimus before moving on to other advanced therapy. Consider etrasimod given UP subgroup in clinical trials. #AIBD2024 @IBDConference

[Samantha Zullow @SamZullowMD]

#AIBD2024 mod-severe UP subgroup seen in etrasimod study; improved outcomes compared to more extensive colitis @IBDConference @mchiorean4

[Samantha Zullow @SamZullowMD]

#AIBD2024 clinical trials stopped early due to significant improvement on tacrolimus for refractory UP. Significant clinical and endoscopic improvement seen. @IBDConference @mchiorean4

[Samantha Zullow @SamZullowMD]

Live from #AIBD2024: Some non-invasive IBD biomarkers are less reliable in ulcerative proctitis including intestinal ultrasound and fecal calprotectin @IBDConference @mchiorean4

[Samantha Zullow @SamZullowMD]

UP risk factors for progression; it is important to explain to patients they have a risk for extension of disease. Up to 20% of pateints require treatment intensification to an advanced therapy
#AIBD2024 @IBDConference

[Samantha Zullow @SamZullowMD]

@CCYANetwork @IBDConference Congrats! Great work.

[Samantha Zullow @SamZullowMD]

Looking forward to presenting on April 1st about transition from peds to adult GI care for people with IBD! Hope to see you there @CCYANetwork @CCfdnNewEngland @PediatricIBD #GITwitter #IBD

[Crohn's & Colitis Foundation - New England @CCfdnNewEngland]

There is still time to register for MyIBD Learning Patient & Caregiver Education Conference on April 1st. We have an excellent line up of presentations. Tickets are $10 and scholarships are available!
View all of the details here: https://t.co/jYce1UPItE

[Dr Sonika Sethi @sonika_sethi]

Our Meta‐analysis is out on @APandT The efficacy of therapeutic drug monitoring of anti‐TNF‐therapy in inflammatory bowel disease https://t.co/bmmIV4nPBJ - proactive TDM showing significant benefits! @Jonathansegal85 @Dr_Dee_Kumar @GastroMJB @JonnyBlackwell

[Samantha Zullow @SamZullowMD]

Great advice for any #GI fellows interested in #IBD fellowship! Reach out to me if you're interested in @BIDMC_GI for IBD fellowship in the future.

[Katie Dunleavy @dunleavy_katie]

📣 Calling all future #IBD fellows!

🍁 Check out our new article in the FALL issue of #ACGMagazine @AmCollegeGastro

Big thank you to our incredible faculty and fellows for their insightful, entertaining and inspiring advice! #BOOM 🔥🫶🏻🌟

⬇️ MUST DO’S for #IBD fellowship! 1/

[IBDJournal & CC360 @IBDJournals]

In this article, @IBD_Houston examines safety data on ustekinumab in 🤰. In this cohort of 39 #IBD pregnancies:
🚫 no specific safety concerns with maternal ustekinumab
🚫no congenital anomalies were reported in newborns
https://t.co/zwRgPiNCeL

[Uma Mahadevan @UmaMahadevanIBD]

Results from PAPooSE group on 82 pregnancies among 77 IBD stoma pts. These are high risk pts needing MFM monitoring. @MySMFM @ColorectalDis https://t.co/pSm1ywHyqU
-->73% C section (24% emergent)
-->24% stoma complication
-->7.5% postpartum hemorrhage
--> 3/77 had bladder injury

[Loren G. Rabinowitz, MD @DrLorenGR]

New article @HarvardHealth on #Familyplanning 🫃with #IBD:
▶️Remission before conception is🔑
▶️Assemble your care team 👨‍⚕️👩‍⚕️🧑‍⚕️
▶️Make sure💉up-to-date, discuss IBD💊 with your👩‍⚕️👨‍⚕️
#NisaDesai @BIDMC_GI @BIDMC_Medicine

https://t.co/CRUJwn6TXk

[BIDMC_GI @BIDMC_GI]

Congratulations to our 13 #BIDMCGI graduates of the Class of 2022! We are so proud of all you have accomplished - in clinic, in endoscopy, through your research, education, & more - you are clinicians of the highest order and we can’t wait to see what you will accomplish next! 🌟

[Shubha Bhat, PharmD @GI_PharmD]

(1/13)📢 New med option for mod to severe Crohn's disease:
Risankizumab-rzaa (Skyrizi) - IL23 antagonist

🏥 Induction: 600 mg IV @ wk 0, 4, 8 (1 hour)
💉Maintenance: 360 mg @ wk 12, then q8 weeks [single-dose prefilled cartridge]

☑️ EIM: psoriatic arthritis, plaque psoriasis